









































J Global Clinical Engineering Vol.7 Issue 1, 2025  2

Editor’s  Corner
Artificial Intelligence in Clinical and Biomedical 
Engineering: Opportunities and Challenges

Never has technology brought so much confusion. For 
some, AI is the savior of humanity; for others, it is an 
agent of destruction. The overwhelming fact is that AI 
is here to stay. But is AI good or bad, and what is its role 
in biomedical and clinical engineering? To answer this, 
we need to understand AI’s capabilities, limitations, and 
evolution while also considering how we should partici-
pate in its development and responsible use.
AI, in a general sense, is an information system capable 
of replicating functions traditionally associated with the 
human brain. From the invention of writing to digital 
calculators and personal computers, AI has evolved into 
today’s large language models—deep artificial neural 
networks capable of processing vast amounts of data and 
mimicking human language. Yet, AI remains a probabilistic 
computational engine that generates responses based 
on its training data. If a system lacks the correct data, it 
may still generate an answer—a phenomenon known as 
hallucination. This raises concerns, particularly in decision 
support, where AI should either provide evidence-based 
guidance or indicate the need for additional information.
AI’s Potential in Clinical and Biomedical Engineering

While AI is still emerging in clinical engineering, several 
areas present significant opportunities:

• Decision Support Systems: AI can assist in procure-
ment, maintenance scheduling, and calibration, 
improving efficiency and decision-making.

• Predictive Maintenance: AI-driven analytics can 
anticipate device failures, minimizing downtime and 
enhancing reliability.

• Inventory Management: AI can optimize medical 
device supply chains, ensuring timely access to 
critical equipment.

• Post-Market Surveillance: AI has the potential to 
enhance monitoring of medical device performance 
and early detection of malfunctions.

• Cybersecurity Measures: As medical devices become 
more connected, AI can detect and prevent cyber-
security threats.

Challenges and Considerations

Despite its promise, AI adoption in clinical engineering 
faces several challenges:

• Data Privacy and Security: Compliance with HIPAA 
and GDPR is essential to protect patient information.

• Algorithmic Bias: AI models must be trained on di-
verse datasets to avoid biases that could negatively 
impact healthcare outcomes. For instance, an AI sys-
tem trained exclusively on maintenance data from a 
single manufacturer may yield recommendations that 
are inapplicable to other brands. Moreover, biases in 
patient datasets can lead to disparities in healthcare 
access and outcomes, making it crucial for clinical 
engineers to contribute to dataset diversification 
and validation.

• Environmental and Operational Context: AI models 
developed in high-resource settings may not perform 
effectively in low- and middle-income (LMI) envi-
ronments, where infrastructure reliability varies. 
AI must be trained with data reflective of different 
operational contexts, including settings with limited 
electricity, refrigeration, and water supply. Clinical 
engineers play a vital role in ensuring AI models 
consider these variables to maintain relevance across 
diverse healthcare environments.

• Explainability and Transparency: AI systems should 
include interpretability layers so that engineers and 
healthcare providers understand the decision-mak-
ing process.

http://www.globalce.org
http://www.globalce.org


3 J Global Clinical Engineering Vol.7 Issue 1, 2025

• Workforce Adaptation: Clinical engineers must seek 
and receive AI training, including ethics and data 
governance, to oversee AI integration safely and 
effectively.

Future Directions and Recommendations

To leverage AI’s potential in clinical and biomedical 
engineering, the following steps should be considered:

1. Develop AI-based decision support systems for main-
tenance, procurement, and calibration.

2. Implement cybersecurity frameworks to safeguard 
AI-driven medical device networks.

3. Diversify AI training datasets by including various pa-
tient populations and multiple medical device brands 
to mitigate algorithmic bias.

4. Ensure AI transparency by integrating explainability 
features to enhance trust and usability.

5. Explore AI applications in predictive diagnosis, early 
failure detection, and resource optimization.

6. Establish AI training programs for clinical engineers 
to promote ethical and effective implementation.

7. Develop domain-specific large language models (LLMs) 
tailored to clinical and biomedical engineering, ensuring 
AI recommendations are contextually appropriate.

8. Publish about best practices, and application of AI into 
Clinical Engineering practices. You may help many to 
avoid missteps shared in your publication.

Conclusion

AI presents a transformative opportunity for clinical and 
biomedical engineering, with the potential to enhance 
safety, efficiency, and decision-making. However, respon-
sible AI adoption requires addressing data privacy, algo-
rithmic bias, and transparency. By proactively engaging 
in AI development and governance, clinical engineers 
can play a pivotal role in shaping the future of healthcare 
technology management.
We must embrace our role as toolmakers, not just users, 
to shape AI into a force for good. Only through intentional 
development can we create ethical, intelligent systems that 
enhance efficiency, reduce risk, and improve the quality 
of life for both patients and technology users. AI is still 
in its infancy, and we must act as responsible teachers 
and stewards, guiding its evolution toward cooperation 
and progress. The alternative is too dangerous—without 
ethical oversight, unscrupulous corporations, negligent 
engineers, or uninformed users could steer AI toward 
harm rather than progress.
 Ricardo Silva

PhD, MBA, CCE

Global expert in Healthcare Digital 
Transformation and Innovation

Copyright © 2025. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY): Creative Commons - 
Attribution 4.0 International - CC BY 4.0. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright 
owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction 
is permitted which does not comply with these terms.

http://www.globalce.org
http://www.globalce.org

